Skip to main navigation

Skip to content

Live - Social Icons

Facebook LinkedIn Twitter

Live - Corporate Menu

Science
Pipeline
Patients & Caregivers
Investors & Media
Leadership
Careers
Contact

Menu

Live - Corporate Menu

Science

Autologous Cellular Theraphy
MCS-NTF Cells
MCS-NTF Cell Production
Publications

Pipeline

Pipeline Overview
Clinical Development Program
ALS
Progressive MS
Publications

Patients & Caregivers

About ALS
About Progressive MS
Clinical Trials
Preapproval Access Policies
Resources

Investors & Media

News
Events and Presentations
Stock Information
Financial Reports & Filings
Corporate Governance

Leadership
Careers
Contact

News

News

Media Contact

Sean Leous
Westwicke/ICR PR
Phone: +1.646.677.1839
Email: sean.leous@icrinc.com

Tools

Email Alerts

Investor Contact

Investor Contact

Investor FAQs

RSS Feeds

Investors

Overview
News
- Press Releases
- Media Contact
Events & Presentations
Stock Information
Financial Reports & Filings
- SEC Filings
- Annual Reports
Corporate Governance

Stock Snapshot

Change

Volume

52 Week High

52 Week Low

May 29, 2020 10:55 PM EDT

Data Provided by Refinitiv. Minimum 15 minutes delayed.

CONTACT

Corporate Headquarters
1325 Avenue of Americas, 28th Floor
New York City, NY 10019
Phone: +1-201-488-0460

R&D Headquarters
12 Bazel Street
POB 10019 Kiryat Aryeh
Petach Tikva 4900101
Phone: +972-3-934-6384

Brainstorm

Science
Pipeline
Patients & Caregivers
Investors & Media
Leadership
Careers
Contact

Live - Social Icons

Facebook LinkedIn Twitter

© Copyright 2020, Brainstorm Cell Therapeutics Inc.. All rights reserved. Website by Chauk.

Live- Footer

Privacy Policy
Terms of Use
Sitemap